ACADIA Pharmaceuticals(ACAD) - 2023 Q4 - Earnings Call Presentation

Fourth Quarter and Full Year 2023 Earnings Call Call Agenda Welcome Al Kildani | Senior Vice President, Investor Relations and Corporate Communications CEO Opening Remarks Steve Davis | President and Chief Executive Officer Commercial Update Brendan Teehan | Chief Operating Officer, Head of Commercial R&D Update Doug Williamson, M.D. | Head of Research and Development Financial Update Mark Schneyer | Chief Financial Officer Closing Remarks Steve Davis | President and Chief Executive Officer Parag Meswani, P ...